ARCHIVES

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

This article is from The Cancer Letter archive.

Vol. 24 No. 07 | February 20, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

Obituary: Connie Curran, 67, C-Change Executive Director

November 21, 2014

Youth Smoking Linked To Exposure In Movies

December 30, 2005

NCI Trials Listed

June 25, 2010

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

January 3, 2014